Kaneka Corporation
Stock Price Chart
2026/10/09 12:26 UpdatedPrice Trend
2026/10/09 12:26 UpdatedPrice & Trading Details
2026/10/09 12:26 UpdatedPRICE
TRADING
Analyst Recommendations 6 analysts
Updated 2026/10/01Earnings Calendar
Updated 2026/10/01Recent Earnings
| Date | EPS Est. | EPS Actual | Surprise |
|---|---|---|---|
| 2024/02/07 | ¥80.10 | ¥69.95 | -12.7% |
| 2020/02/11 | ¥63.70 | ¥48.85 | -23.3% |
| 2019/08/07 | ¥92.00 | ¥53.53 | -41.8% |
| 2019/02/07 | ¥105.50 | ¥60.94 | -42.2% |
Shareholder Composition
Updated 2026/10/01Top Mutual Funds / ETFs
Updated 2026/10/01Major Holders
Updated 2026/10/01| Fund Name | Ownership | Shares | Change |
|---|---|---|---|
|
American Century ETF Trust-Avantis International Small Cap Value ETF
|
1.2M | +2.40% | |
|
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund
|
679.9K | 0.00% | |
|
DFA INVESTMENT DIMENSIONS GROUP INC-DFA Intl Small Cap Value PORT.
|
680.6K | 0.00% | |
|
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund
|
463.9K | 0.00% | |
|
Victory Portfolios-Victory Trivalent International Small-Cap Fund
|
316.5K | 0.00% | |
|
Templeton Global Smaller Companies Fund
|
302.6K | -15.31% |
Dividend History 3Years Growth
Updated 2026/10/04| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥185 | +23.3% |
| 2025 | ¥150 | +30.4% |
| 2024 | ¥115 | +4.5% |
| 2023 | ¥110 | -4.3% |
| 2022 | ¥115 | - |
Financial Performance
2026/10/04 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥691,530M | ¥755,821M | ¥762,302M | ¥807,200M |
| Gross Profit | ¥196,649M | ¥198,926M | ¥204,214M | ¥225,644M |
| Operating Income | ¥43,563M | ¥35,088M | ¥32,579M | ¥40,050M |
| Pretax Income | ¥37,469M | ¥34,338M | ¥40,169M | ¥40,796M |
| Net Income | ¥26,487M | ¥23,008M | ¥23,220M | ¥25,309M |
| EPS | ¥404.95 | ¥348.66 | ¥356.87 | ¥399.67 |
| Operating Margin | 6.30% | 4.64% | 4.27% | 4.96% |
| Balance Sheet | ||||
| Total Assets | ¥726,959M | ¥782,640M | ¥870,205M | ¥920,143M |
| Total Equity | ¥387,768M | ¥417,992M | ¥454,110M | ¥471,934M |
| Total Liabilities | ¥339,191M | ¥364,648M | ¥416,095M | ¥448,209M |
| Cash | ¥41,735M | ¥41,774M | ¥43,969M | ¥45,639M |
| Interest-bearing Debt | ¥132,829M | ¥175,943M | ¥195,095M | ¥223,058M |
| Equity Ratio | 53.34% | 53.41% | 52.18% | 51.29% |
| D/E Ratio | 0.34 | 0.42 | 0.43 | 0.47 |
| Cash Flow | ||||
| Operating CF | ¥34,106M | ¥28,710M | ¥61,911M | ¥41,252M |
| Investing CF | -¥39,595M | -¥41,970M | -¥58,771M | -¥55,038M |
| Financing CF | -¥1,105M | ¥12,352M | -¥1,519M | ¥14,453M |
| Free CF | -¥5,824M | -¥13,281M | -¥3,355M | -¥14,729M |
| Efficiency | ||||
| ROE | 6.83% | 5.50% | 5.11% | 5.36% |
| ROA | 3.64% | 2.94% | 2.67% | 2.75% |
Latest IR Information
-
Notice Regarding Share Buyback Status
From September 1, 2026 to September 30, 2026, 153,300 shares of common stock were acquired via market purchase for a total of 926,593,200 yen. The upper limit is set at 2.32% of the total outstanding shares and 7,000 million yen,...
Read more -
Notice Regarding Share Buyback Activity
Acquisition period: August 1, 2026 to August 31, 2026; Shares acquired: 42,300 common shares; Total acquisition amount: ¥256,177,200; Acquisition method: market purchase. Cumulative total: 231,600 shares, ¥1,319,257,700. The cap is 1,400,000 shares and ¥70 billion, and the ongoing acquisition period...
Read more -
Kaneka: Q1 Fiscal 2027 Financial Summary
Announces the Q1 results for the fiscal year ending March 2027. Highlights include year-over-year comparisons for net sales, operating income, ordinary income, and net income attributable to owners of the parent. The document includes a breakdown of net sales by...
Read more -
FY2027 Q1 Earnings Presentation
Revenue was 223.0 billion yen, up 12.3% year over year, with operating income of 14.9 billion yen, up 83.1% YoY. Segments Materials/SU Quality of Life, Health Care, and Nutrition performed well. Going forward, growth strategies for each segment are expected...
Read more -
Notice on the Status of Share Buyback
From July 1, 2026 to July 31, 2026, ordinary shares were repurchased. Number of shares acquired: 102,600 shares, total acquisition value: 58,227万3千円. Upper limit: 1,400,000 shares, share buyback period: 2026/5/15–2027/3/24. Cumulative through July 31: 189,300 shares, total value 10億63百万円.
Read more
Latest News (5 items)
-
Average Analyst Rating: hold
Average Target Price: ¥5,542
Rating Score: 3.00 (Based on 6 analysts)
※1=Strong Buy, 5=Strong Sell
Company Information
About
Kaneka Corporation engages in the manufacture and sale of polyvinyl chloride (PVC), crosslinked PVC, PVC-PVAc polymers, paste PVC, acryl grafted-vinyl chloride copolymer, and chlorinated PVC in Japan, Asia, North America, Europe, and internationally. It offers impact modifiers, processing aids, specialty additives, toughener for thermosetting resins, silyl-terminated polyether, acrylic silicon, terminally reactive liquid acrylic, biodegradable polymer, engineering resin for injection molding, acrylic film, and isobutylene-based thermoplastic elastomer products. The company also offers polypropylene and kanelite foams, extruded polystyrene foam insulation, polyimide film, transparent film for optical use, high thermal conductive graphite sheets, multi-layer insulation, transparent conductive film, and thermo-resistant, and light-resistant transparent resin products. In addition, it provides photovoltaic power generation systems for residences, public, and industrial installations; eco fur, flame-retardant, hair accessory, and new materials; and organic EL lighting panels, lithium-ion battery, and biosurfactant. Further, the company offers intervention, blood purification, gastroenterology intervention, testing equipment, regenerative medicine and cell therapy, and genetic diagnostic products; and low molecular pharmaceutical materials, affinity chromatography resin for purification of a monoclonal antibody, biopharmaceuticals, transdermal medicine, and innerwear with shock-absorbing pad. Additionally, it provides dairy products, yogurt, margarine, fat and oils, whipping cream, filling, baker's yeast/ dough improver, processed fruits, butter, shortening, cacao butter alternatives, cream for kneading and other uses, frozen dough, spices, antifreeze materials; and pharma and supplemental nutrition solutions, which include coenzyme, probiotics, and dietary ingredients, as well as fertilizers. The company was incorporated in 1949 and is headquartered in Tokyo, Japan.